The D.C.-based consumer-advocacy group Public Citizen is calling for a federal investigation of the University of Minnesota’s human-subjects protection program — and says the program’s accreditation should be rescinded. The announcement, made today, comes after a strongly worded external review last month said the U was not doing enough to protect the subjects of its Read more →
It says the Board of Regents has not been the watchdog it should be in problematic drug-trial cases. Read more →
This year didn’t spare any sector of Minnesota higher education from headlines.
Campuses in the public, for-profit and nonprofit sectors struggled with crime, labor dissatisfaction, legal troubles or complaints over race relations. Read more →
Despite the concerns of some faculty and observers, an upcoming review of University of Minnesota clinical research practices will be independent, the U said. Read more →
Scholars had been raising questions over the 2004 suicide of patient Dan Markingson in a university drug trial, and how the U had handled his involvement in the trial. Read more →
University of Minnesota bioethics professor Leigh Turner writes on his blog, Health in the Global Village, that the university’s agreement to hold an outside review of the U’s clinical research practices seems hollow. (The call for a review came amid lingering questions over university practices during a 2004 drug study, in which a patient committed Read more →
Academic Matt Lamkin writes in the Star Tribune on behalf of about a dozen University of Minnesota scholarly alumni about concerns they have with a coming outside review of the U’s clinical research practices. In essence, they fear the review will never really get to the heart of what practices or policies may have caused Read more →
University of Minnesota President Eric Kaler says he will form an outside panel to review how the U treats human subjects in clinical trials. His announcement followed a faculty resolution today requesting a review of the U’s practices. (See Item No. 10 on the second-to-last page above.) The panel is a response to the 2004 Read more →
Alex Friedrich